IL53636A - 7-halo-3,20-dioxo-1,4-pregnadienes and-4-pregnenes and their preparation and pharmaceutical compositions containing them - Google Patents

7-halo-3,20-dioxo-1,4-pregnadienes and-4-pregnenes and their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53636A
IL53636A IL53636A IL5363677A IL53636A IL 53636 A IL53636 A IL 53636A IL 53636 A IL53636 A IL 53636A IL 5363677 A IL5363677 A IL 5363677A IL 53636 A IL53636 A IL 53636A
Authority
IL
Israel
Prior art keywords
pregnadienes
pregnenes
dioxo
halo
preparation
Prior art date
Application number
IL53636A
Other languages
English (en)
Other versions
IL53636A0 (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IL53636A0 publication Critical patent/IL53636A0/xx
Publication of IL53636A publication Critical patent/IL53636A/xx

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IL53636A 1976-12-22 1977-12-19 7-halo-3,20-dioxo-1,4-pregnadienes and-4-pregnenes and their preparation and pharmaceutical compositions containing them IL53636A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (2)

Publication Number Publication Date
IL53636A0 IL53636A0 (en) 1978-03-10
IL53636A true IL53636A (en) 1983-05-15

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53636A IL53636A (en) 1976-12-22 1977-12-19 7-halo-3,20-dioxo-1,4-pregnadienes and-4-pregnenes and their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
JP (1) JPS604198B2 (pt)
AR (1) AR226806A1 (pt)
AT (2) AT373269B (pt)
BE (1) BE862089A (pt)
DE (1) DE2756550C2 (pt)
DK (1) DK153494C (pt)
FI (1) FI63947C (pt)
FR (1) FR2384793A1 (pt)
GB (1) GB1575983A (pt)
HK (1) HK584A (pt)
HU (1) HU179784B (pt)
IE (1) IE45950B1 (pt)
IL (1) IL53636A (pt)
MY (1) MY8500082A (pt)
NL (1) NL180479C (pt)
NO (1) NO151826C (pt)
NZ (1) NZ186031A (pt)
PT (1) PT67432B (pt)
SE (1) SE429865B (pt)
SG (1) SG58683G (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
NL180479C (nl) 1987-03-02
DE2756550C2 (de) 1986-10-16
NL7714056A (nl) 1978-06-26
AR226806A1 (es) 1982-08-31
JPS5379850A (en) 1978-07-14
FI63947C (fi) 1983-09-12
ATA575980A (de) 1982-04-15
DE2756550A1 (de) 1978-07-06
DK153494C (da) 1989-02-20
BE862089A (fr) 1978-06-20
FR2384793A1 (fr) 1978-10-20
HU179784B (en) 1982-12-28
SE429865B (sv) 1983-10-03
MY8500082A (en) 1985-12-31
JPS604198B2 (ja) 1985-02-01
IE45950L (en) 1978-06-22
PT67432B (en) 1979-05-23
ATA909477A (de) 1983-05-15
SG58683G (en) 1985-01-11
FR2384793B1 (pt) 1981-11-13
FI63947B (fi) 1983-05-31
NO151826B (no) 1985-03-04
AT373269B (de) 1984-01-10
PT67432A (en) 1978-01-01
SE7714538L (sv) 1978-06-23
NL180479B (nl) 1986-10-01
DK153494B (da) 1988-07-18
IE45950B1 (en) 1983-01-12
AT377566B (de) 1985-04-10
NO151826C (no) 1985-06-12
HK584A (en) 1984-01-13
IL53636A0 (en) 1978-03-10
GB1575983A (en) 1980-10-01
FI773825A (fi) 1978-06-23
DK569977A (da) 1978-09-28
NO774359L (no) 1978-06-23
NZ186031A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL53063A (en) Phenoxy-amino-propanols,processes for their preparation and pharmaceutical compositions comprising them
IL52131A (en) Substituted 4-amino-4-arylcyclohexanones and their ketals,their preparation and pharmaceutical compositions containing them
IL51816A (en) Steroids,their preparation and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
IL52867A (en) Phenethylaminoalkyl isoquinolinones and benzazepinones,their preparation and pharmaceutical compositions containing same
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL53420A (en) Oxepane derivatives,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
IL52615A (en) 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them
MY8000099A (en) Isobutyramides, their preparation and therapeutic compositions containing them
IL52137A (en) N-heterocyclic-n-(hetero)arylfluoroalkylamines,their preparation and pharmaceutical compositions containing them
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL51373A (en) Pharmaceutical compositions containing halocinnamides,certain such compounds and their preparation
IL52952A (en) Hydroxymethyl-pyridine esters,their preparation and pharmaceutical compositions containing them
IL56021A (en) 2-heterocyclylalklyl-6-methoxy-naphathalenes,their preparation and pharmaceutical compositions containing them